We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

50 hedge funds and large institutions have $1.75M invested in Bionano Genomics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

460% more call options, than puts

Call options by funds: $56K | Put options by funds: $10K

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

6% more funds holding

Funds holding: 47 → 50 (+3)

0.01% less ownership

Funds ownership: 0.11% → 0.1% (-0.01%)

29% less capital invested

Capital invested by funds: $2.47M → $1.75M (-$720K)

Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
11
Reduced
9
Closed
7
Calls
$56K
Puts
$10K
Net Calls
+$46K
Net Calls Change
-$36K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$145K
2
Jane Street
Jane Street
New York
+$117K
3
Group One Trading
Group One Trading
Illinois
+$75K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.7K
5
Renaissance Technologies
Renaissance Technologies
New York
+$45.1K

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$241K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$89K
3
Citadel Advisors
Citadel Advisors
Florida
-$70.9K
4
TSS
Two Sigma Securities
New York
-$64.7K
5
GCP
GSA Capital Partners
United Kingdom
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
26
SBI Securities
Japan
$2.64K +$2.6K +152 New
Citigroup
27
Citigroup
New York
$2.03K – – –
Wells Fargo
28
Wells Fargo
California
$2K +$1.37K +80 +222%
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
$843 – – –
Credit Agricole
30
Credit Agricole
France
$764 – – –
Bank of America
31
Bank of America
North Carolina
$344 +$34 +2 +11%
GWSG
32
GPS Wealth Strategies Group
Colorado
$288 – – –
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$274 +$273 +16 New
CFGS
34
Concourse Financial Group Securities
Alabama
$241 – – –
JP Morgan Chase
35
JP Morgan Chase
New York
$222 – – –
TWC
36
TD Waterhouse Canada
Ontario, Canada
$145 – – –
Fidelity Investments
37
Fidelity Investments
Massachusetts
$118 -$103 -6 -46%
FFA
38
Farther Finance Advisors
California
$92 +$85 +5 New
AF
39
Allworth Financial
California
$75 – – –
AWM
40
Activest Wealth Management
Florida
$58 – – –
AWM
41
AllSquare Wealth Management
New York
$58 – – –
Barclays
42
Barclays
United Kingdom
$58 – – –
Jones Financial Companies
43
Jones Financial Companies
Missouri
$53 – – –
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$37 – – –
MA
45
Modus Advisors
Minnesota
$35 +$34 +2 New
AF
46
Aviso Financial
Ontario, Canada
$29 – – –
MWA
47
Medallion Wealth Advisors
Connecticut
$25 +$17 +1 New
Fifth Third Bancorp
48
Fifth Third Bancorp
Ohio
$20 – – –
CLOS
49
Compagnie Lombard Odier SCmA
Switzerland
$6 – – –
SS
50
Sunbelt Securities
Texas
$4 – – –
1
2
3

BNGO Hedge Fund Activity: Q4 2024 in Review

50 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2024, worth a combined $1.75M — down 29% from $2.47M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BNGO positions and 7 closed out — a net gain of 5 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $145K. The largest seller was GMT Capital, exiting entirely with an estimated $241K sold.

  • 50 institutional investors held Bionano Genomics (BNGO) as of Q4 2024, up from 47 in Q3 2024.
  • Funds reported $1.75M of Bionano Genomics stock for Q4 2024, down 29% quarter-over-quarter.
  • 12 funds opened new Bionano Genomics positions in Q4 2024 and 7 closed out, a net change of +5 holders.
  • The largest Bionano Genomics buyer in Q4 2024 was Morgan Stanley, an estimated $145K added.
  • The largest Bionano Genomics seller in Q4 2024 was GMT Capital, an estimated $241K sold.

Based on aggregated 13F filings for Q4 2024.